RGEN:NASDAQ
Repligen Corp
$194.57
0.00%
(0.00) 1D
$195.07
arrow_upward
+0.26% (+0.50)todayPre-market
Sarado: Set 29, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa RGEN...
Mkt. cap
10.98B
Avg. na dami
1.07M
Dami
4.48K
P/E ratio
265.22
Mataas nang 52-wk
$198.87
Mababa nang 52-wk
$100.99
EPS
$0.73
Beta
1.05
Mga natitirang share
56.44M
Bilang ng mga empleyado
2K
Mkt. cap
10.98B
Avg. na dami
1.07M
Dami
4.48K
P/E ratio
265.22
Mataas nang 52-wk
$198.87
Mababa nang 52-wk
$100.99
EPS
$0.73
Beta
1.05
Mga natitirang share
56.44M
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Investing.com
·
23 oras ang nakalipas
Repligen stock price target reaffirmed at $225 by UBS on growth outlook
TradingView
·
1 araw ang nakalipas
Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs?
Investing.com UK
·
1 araw ang nakalipas
Form 4 Repligen Corporation For: 28 September By Investing.com
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
Tungkol sa Repligen Corp
CEOTony J. Hunt
Mga Empleyado2K
Itinatag1981
HeadquartersWaltham, Massachusetts, Estados Unidos
Sektor-
Websiterepligen.com